Safety and Pharmacokinetics in healthy subjects
Showing 1 - 25 of >10,000
The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese
Active, not recruiting
- The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
- Mindeudesivir hydrobromide tablets and Clarithromycin tablets
- Mindeudesivir hydrobromide tablets and Cyclosporine softgels
-
Zhengzhou, Henan, ChinaZhengzhou Sixth People's Hospital
Aug 15, 2023
Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab
Not yet recruiting
- Healthy Male Subjects
- Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
- Pembrolizumab injection
- (no location specified)
Oct 30, 2023
Pharmacokinetics Trial in Shanghai (ZX-7101A)
Not yet recruiting
- Pharmacokinetics
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jul 17, 2023
Healthy Participants, Chronic Spontaneous Urticaria Trial in Anniston (AK006, Placebo)
Recruiting
- Healthy Participants
- Chronic Spontaneous Urticaria
- AK006
- Placebo
-
Anniston, AlabamaSite 601-001 Healthy Volunteer Clinical Research Unit
Oct 2, 2023
Healthy Trial in Sichuan (THDB0206 injection, Humalog®, BC222insulin lispro injection)
Completed
- Healthy
- THDB0206 injection
- +2 more
-
Sichuan, ChinaWest China Hospital of Sichuan University
Nov 22, 2023
Healthy Volunteers Trial (ABBV-903, Placebo for ABBV-903)
Not yet recruiting
- Healthy Volunteers
- ABBV-903
- Placebo for ABBV-903
- (no location specified)
Aug 21, 2023
Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)
Recruiting
- Diabetes
- INS062 injection
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 8, 2023
Malignant Tumor Trial (SHR2554 tablet dosing, Omeprazole tablet dosing)
Not yet recruiting
- Malignant Tumor
- SHR2554 tablet dosing
- Omeprazole tablet dosing
- (no location specified)
Oct 17, 2023
Prevention of Graft Rejection After Organ Transplantation Trial in Beijing (SHR-3032, SHR-3032 Placebo)
Not yet recruiting
- Prevention of Graft Rejection After Organ Transplantation
- SHR-3032
- SHR-3032 Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 13, 2023
Chronic HBV Infection Trial in Chongqing (PA3670)
Recruiting
- Chronic HBV Infection
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
May 6, 2023
Healthy Trial in Miami (CORT125134 150 mg, CORT125134 250 mg, CORT125134 dose to be determined)
Completed
- Healthy
- CORT125134 150 mg
- +2 more
-
Miami, FloridaQuotient Sciences, Miami, Inc.
Oct 17, 2023
Healthy Volunteers Trial in Chang chun (CB06-036)
Recruiting
- Healthy Volunteers
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 19, 2023
Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)
Not yet recruiting
- Healthy
- Y-2 Sublingual Tablet
- Placebo
-
Glendale, CaliforniaParexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023
Healthy Volunteer Study Trial in Cypress (Bemnifosbuvir (BEM))
Completed
- Healthy Volunteer Study
- Bemnifosbuvir (BEM)
-
Cypress, CaliforniaAtea Study Site
Jun 14, 2023
Hiv Trial (LP-98 injection)
Not yet recruiting
- Hiv
- LP-98 injection
- (no location specified)
Jun 27, 2023
Healthy Volunteers Trial in Qingdao (SIM0278 Injection/Placebo)
Recruiting
- Healthy Volunteers
- SIM0278 Injection/Placebo
-
Qingdao, China, Shandong, ChinaAffiliated Hospital of Qingdao University
Aug 31, 2023
Healthy Trial in Turku (KAND567, Placebo)
Completed
- Healthy
- KAND567
- Placebo
-
Turku, FinlandClinical Research Services Turku (CRST)
Sep 1, 2023
Healthy Subjects (Indication: Asthma) Trial in Harrow (Elarekibep, Placebo)
Not yet recruiting
- Healthy Subjects (Indication: Asthma)
- Elarekibep
- Placebo
-
Harrow, United KingdomResearch Site
Mar 20, 2023
Healthy Subjects Trial in SEoul (C1K, Placebo)
Recruiting
- Healthy Subjects
- C1K
- Placebo
-
SEoul, Korea, Republic ofSeoul National University Clinical Trial Center
Aug 3, 2023